Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and Outcomes.

Malignant STAT3-JAK2 fusion genes T cell lymphoma T cell tumors T-cell malignancies gastrointestinal symptoms immunological markers

Journal

Clinical lymphoma, myeloma & leukemia
ISSN: 2152-2669
Titre abrégé: Clin Lymphoma Myeloma Leuk
Pays: United States
ID NLM: 101525386

Informations de publication

Date de publication:
08 2022
Historique:
received: 11 02 2022
revised: 18 03 2022
accepted: 03 04 2022
pubmed: 3 5 2022
medline: 20 7 2022
entrez: 2 5 2022
Statut: ppublish

Résumé

Lymphoproliferative diseases arise when the physiological mechanisms that control the proliferation of T and B lymphocytes are disrupted, resulting in an uncontrolled and autonomous increase in immune cells leading to lymphocytosis and lymphadenopathy, and often to the involvement of extranodal sites. The differential diagnosis of malignant T cell tumors involves other neoplasms and non-clonal T cell proliferations. Immunological markers are essential, as a first step, to distinguish between T-cell and non-T-cell disorders. It must be established based on the configuration of the genes of the TCR chain to rule out that the picture is not reactive to other underlying diseases. This clinical review and accompanying case reports highlight the diagnostic challenges associated with indolent lymphoproliferative T-cell disorders, which in many cases may represent the clinical manifestation of a single disease. Particularly we focus on gastrointestinal manifestations that could be expression either of lymphoproliferative disorder either of autoimmune disease either of both. The correct interpretation of the different clinical situations can help in the diagnostic and therapeutic process.

Identifiants

pubmed: 35501257
pii: S2152-2650(22)00115-X
doi: 10.1016/j.clml.2022.04.002
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e745-e750

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Pierluigi Masciopinto (P)

Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.

Emilio Bellitti (E)

Pathology Unit, AOUC Policlinico, Bari, Italy.

Elena Arcuti (E)

Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.

Olga Battisti (O)

Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.

Gerardo Cazzato (G)

Pathology Unit, AOUC Policlinico, Bari, Italy.

Tommasina Perrone (T)

Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.

Maria Chiara Longo (MC)

Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.

Filomena Emanuela Laddaga (FE)

Clinical Pathology Unit, AOUC Policlinico, Bari, Italy.

Eugenio Maiorano (E)

Pathology Unit, AOUC Policlinico, Bari, Italy.

Pellegrino Musto (P)

Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.

Giuseppe Ingravallo (G)

Pathology Unit, AOUC Policlinico, Bari, Italy.

Francesco Gaudio (F)

Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy. Electronic address: fragaudio@alice.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH